-

XiFin Appoints Erik Sallee as Chief Financial Officer

CFO Brings Extensive Capital Markets Experience Leading Companies Through Market Expansion

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, announced today that it has appointed Erik Sallee as its new chief financial officer and executive vice president.

Prior to joining XiFin, Sallee was CFO at Intuitive Machines (NASDAQ: LUNR), a diversified space exploration company recognized for leading the United States’ return to the moon for the first time since Apollo. In this role, he guided the company from Series B to a successful public listing on the NASDAQ, raising substantial capital in the process.

Recognized for skillfully navigating finance within best-in-class organizations throughout his career, Sallee joins at a pivotal moment in XiFin's trajectory, as the company positions itself for growth, pursuing timely market opportunities through resourceful financial strategies.

“Erik’s exceptional standing as a financial leader and his track record of shaping financial strategies for innovative and swiftly growing enterprises are vital to XiFin,” said XiFin Executive Chair and Chief Executive Officer Lâle White. “Erik is perfectly suited to accelerate our plans for growth as we focus on market expansion in radiology, pharmacy, and hospital services.”

“I'm proud to be joining XiFin's mission-driven team to shape the future of healthcare,” said Sallee. “XiFin’s success is rooted in delivering cutting-edge technology and exceptional value that empower our customers to provide the best possible healthcare. I look forward to working with XiFin’s visionary leaders to advance this thriving business model and capitalize on our growth opportunities.”

In addition to driving the implementation of XiFin's pivotal financial and market expansion strategies, Sallee will lead XiFin's administrative finance operations, emphasizing a commitment to the principles of “servant leadership” with a focus on accountability, adaptability, efficiency, and greater profitability.

Sallee began his career in the U.S. Marine Corps, and has since held various senior and executive finance roles. In 2013, he was appointed CFO of Raytheon Solipsys, followed by L3 Technologies, Blue Origin, and Intuitive Machines. He earned a B.S. in Political Science from Vanderbilt University and an M.S. and M.B.A. in Finance from University of Maryland College Park. He attended The Wharton School of Business Executive Leadership Program in 2017 and is a licensed Certified Public Accountant.

About XiFin

XiFin is a healthcare information technology company that empowers healthcare organizations to navigate an increasingly complex and evolving healthcare landscape. Through innovative AI-enabled technologies and services, we deliver operational efficiency, interoperability, and simplicity. The company’s revenue cycle management, clinical workflow enablement, laboratory information system, and patient engagement solutions enable organizations to achieve stronger finances, streamline operations, and develop industry-leading business strategies. XiFin solutions deliver THE POWER TO DO GOOD™ so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.

Contacts

Audrey Chang
202-489-8634
a.chang@togorun.com

XiFin, Inc.

Details
Headquarters: San Diego, CA
CEO: Lâle White
Employees: 900+
Organization: PRI

Release Versions

Contacts

Audrey Chang
202-489-8634
a.chang@togorun.com

Social Media Profiles
More News From XiFin, Inc.

Diagnostic Lab Claim Denials Jumped 40% in 2025, New XiFin Research Report Finds

SAN DIEGO--(BUSINESS WIRE)--Denials of clinical laboratory, molecular diagnostic, and genomics claims rose to 11.2% in 2025 from 8.0% the year before, a 40% jump that erased two years of improvement, according to the recently released 2026 Payor Denial Impact Report from XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM). The report is based on an analysis of more than 30 million claims processed through XiFin’s Empower RCM solution, which serves 11 of the 15 largest laboratorie...

XiFin Launches Fourth Annual Pharmacy Transformation Outlook Survey as Legislative Action Moves to Reshape Pharmacist-Provided Care

SAN DIEGO--(BUSINESS WIRE)--In recognition of American Pharmacists Month, XiFin, Inc., a leading provider of AI-driven revenue cycle management (RCM) solutions and services to more than half of U.S. pharmacies, today opened its fourth annual Pharmacy Transformation Outlook Survey. The research will gather perspectives from pharmacy professionals on reimbursement, specialty pharmacy growth, clinical services, AI adoption, and operational barriers, and will seek to support national advocacy and in...

Frost Radar™ Recognizes XiFin as the Only AI-enabled Ancillary Healthcare RCM Specialist Among Leading North American Providers

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM), today announced it has been recognized in the Frost Radar™: Revenue Cycle Management Operations in North America. Frost & Sullivan evaluated more than 100 companies and identified XiFin as one of only 15 providers recognized on its Growth and Innovation indices, and the only company focused exclusively on ancillary healthcare revenue cycle management. Frost & Sullivan estimates the North Amer...
Back to Newsroom